Head and neck cancer - Institucional experience with 2 years of follow up
DOI:
https://doi.org/10.34631/sporl.593Keywords:
cancer, head and neck, survival, surveillance, follow-upAbstract
Head and Neck Cancer is a prevalent disease in our department and requires a multidisciplinary approach. The aim of this study was to group our statistic data in order to compare our data with national and international references and to detect some aspects of evaluation and surveillance that could be changed or meliorated.
We designed a retrospective study on the head and neck cancer patients that started their first oncologic treatment during the years of 2008 and 2009 (total of 111 patients). We evaluated the gender, age, histopathology, anatomic location of the tumor and stage. We also evaluated the therapeutic options, the response to them, the 2 year survival and the disease-free survival. We identified the need to design larger and more homogeneous studies and we meliorated and standardized the quality of the clinical data record. We also realized that there is an urgent need to invest in a primary prevention near the people.
References
Stenson K, Brockstein B, Overview of head and neck cancer, UptoDate (online), Fev 2012, Acedido em fevereiro de 2012.
Poon C, Stenson K, Overview of the diagnosis and staging of head and neck cancer, UptoDate (online), Fev 2012, Acedido em fevereiro de 2012.
Carneiro B., et al, Overview of treatment for head and neck squamous cell cancer, UptoDate (online), Fev 2012, Acedido em fevereiro de 2012.
Edge SB, et al. American Joint Committee on Cancer Staging Manual. 7th Edition, Springer, New York; 2010.
Browning G., et al. Epidemiology of head and neck cancer. In: Scott-Brown‘s Otorhinolaryngology, Head and Neck Surgery, 7th Edition. London, Hodder Arnold; 2008: pp2343-2350.
Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994; 120:934-39.
Ritoe SC, de Vegt F, Scheike IM, et al. Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis. Cancer 2007; 109:239-47.
Ritoe SC, Krabbe PF, Kaanders JH, et al. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer 2004; 101:1382-9.
Schwartz DL, Barker J Jr, Chansky K, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma - too much for too little? Head Neck 2003; 25:990-9.
Boysen M, Lövdal O, Tausjö J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426-30.
Francis DO, Yueh B, Weymuller EA Jr, Merati AL. Impact of surveillance on survival after laryngeal cancer in the medicare population. Laryngoscope 2009; 119:2337-44.
Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001; 258:177-83.
National Comprehensive Cancer Network®, NCCN Clinical Practice Guidelines in OncologyTM Head and Neck Cancer, V.2.2010
Saba N., et al, Posttreatment surveillance of head and neck cancer, UptoDate (online), Fev 2012, Acedido em fevereiro de 2012.
